Benefits of Screening in EDs
Screening for HIV, HCV, & syphilis in EDs has been shown to detect unidentified & untreated infections. Evaluation studies on various screening models have been published by EDs across the country. CDPH has also interviewed four CA EDs that have implemented opt-out HIV, HCV, & syphilis screening programs. Based on literature & experience, ED screening programs can:
Published Literature
CA Emergency Departments
-
Increase access to testing
-
Reduce healthcare costs due to increased & earlier treatment of STIs
-
Reduce transmission due to early detection & treatment
-
āIncrease screening & treatment of individuals who are undiagnosed
ā
Lessons Learned from EDs
EDs in CA that have implemented routine, opt-out HIV, HCV, & syphilis screening programs have noted several keys to the successful implementation of this initiative. It may be important to consider the following emerging best practices during implementation:
Garner buy-in from staff
-
Have a champion within both the ED & the public health department to generate excitement & buy-in.
- Have
conversations with other EDs that are already implementing screening programs.
-
Include key decision makers impacted by the screening protocol (e.g., ED providers, nursing, front desk staff, IT, lab, finance, administration) from the outset & get their buy-in.
-
Educate staff on new screening & treatment protocols including opt-out screening, empiric treatment in the ED, linkage to care, & automated ordering. Consider ways that your local health department could support this process (e.g., trainings/in-services, virtual learning opportunities).
Identify protocols and workflows
-
Consider implementing HIV, HCV, & syphilis at the same time to streamline implementation.
-
Automate the test ordering process via EMR algorithms to identify individuals for testing, limit impacts to existing workflows, & reduce opportunities for human error, if possible.
-
Separate, written consent is
not required for HIV testing. Opt-out testing ā in which the patient if notified that testing will be performed unless they decline ā is recommended by the CDC as best clinical care, regardless of reported risk behaviors.
-
Identify opportunities to reduce laboratory turnaround time (e.g., reflex testing for confirmatory tests, processing tests in-house) so that initial results can be obtained, & the patient can be treated prior to discharge.
-
Utilize
HIV,
HCV, and
syphilis testing & Treatment algorithms to facilitate empiric treatment in the ED to reduce lost to follow up & failure to initiate treatment.
Consider who will follow-up on positives and linkage to care
- Prior to roll-out,
determine
standard operating procedures (.doc) (SOPs) for (1) patients who test positive including
identification of who at the hospital & the health department will ensure treatment & seamless linkage to care, and (2)
notifying patients who have negative confirmatory tests to discontinue treatment.
- When possible,
expand linkage to care services during the times of the day when you see the most patients (e.g., outside of business hours) ā
Potential Funding Sources
To support HIV, HCV, & syphilis screening, emergency departments (EDs) may be able to leverage one or more existing local, state, and/or federally funded initiatives below:
County General Funds
Some counties may have discretionary funds available for priority public health initiatives. For more information, contact your local board of supervisors, city council, or your local health department.
Department of Health Care Services
DHCS oversees Medi-Cal along with state-funded mental health and substance use disorder services. Their listserv often includes funding announcements as well as information on implementation of Cal-AIM (described in more detail below). Find out more about how to join the DHCS listserv on the
DHCS websiteā.
Industry
Some private companies, such as medication manufacturers and pharmacies, have given limited-term funding to help EDs establish the infrastructure to implement routine opt-out testing for syphilis, HIV, and HCV.
Medi-Cal Managed Care Plans
Medi-Cal Managed Care Plans (MCPs) are responsible for implementing California Advancing and Innovating Medi-Cal (CalAIM), including through contracts with local organizations. MCPs often have flexibility to pilot different collaborative models to achieve desired improvements in patient outcomes. Given the complexity of Cal-AIM, approaching local MCPs may be a useful strategy to identify which components could be leveraged to support ED and MCPsā mutual goals. Potential initiatives within Cal-AIM and/or Medi-Cal for exploration include, but are not limited to:
Local Public Health Departments (LHDs)
Some LHDs may have syphilis, HIV, and/or HCV funding available from the California Department of Public Health (CDPH), including to support routine opt-out testing in emergency departments. This could include direct funding or in-kind support, such as embedding disease investigation specialists in the ED.
ā Note: LHDs may have limitations in their ability to support testing in their local EDs, including state rules limiting local partnerships to non-profit entities or funding being earmarked for other priority activities. Nevertheless, EDs should reach out to their LHDs to explore potential opportunities for collaboration. For EDs who need assistance identifying a contact at your LHD, please contact
[email protected].
Opioid Settlement Funds
California has entered into multiple settlement agreements with companies that may have contributed in some way to the prescription opioid epidemic. Many of these opioid settlement funds have been allocated for use by city and county governments for a range of allowable activities outlined in
Exhibit E (PDF) of the National Opioid Settlement Agreements. Allowable activities include, but are not limited to: āā
-
Expanding access to testing and treatment for infectious diseases such as HIV and Hepatitis C resulting from intravenous opioid use.
-
Providing training in harm reduction strategies to health care providers, students, peer recovery coaches, recovery outreach specialists, or other professionals that provide care to persons who use opioids or persons with [opioid use disorder] and any cooccurring [substance use disorder/mental health] conditions.
-
Provide comprehensive syringe services programs with more wrap-around services, including linkage to opioid use disorder treatment, access to sterile syringes and linkage to care and treatment of infectious diseases.
Responsibility for managing the use of opioid settlement funds varies by city and county. Potential contacts may include the local behavioral health director, local health officer, sheriffās department, or opioid safety coalition. For more information, visit the
DHCS Opioid Settlement Fundsā website.ā
Sierra Health Foundation
Sierra Health Foundation often manages federally funded substance use disorder initiatives for DHCS. They frequently release funding announcements for local and community applicants. To learn more about current projects and to join their mailing list, visit the
Sierra Health Foundation website.
References
1
Dear Colleague Letter: Call to Expand HIV and Syphilis Testing for Pregnant Women (PDF); California Department of Public Health. November 2021.
2
HIV Testing in Emergency Departments: Findings and Recommendations Assembly Bill No. 2439 (PDF); California Department of Public Health. November 2019.
3
Trends in the Utilization of Emergency Department Services, 2009- 2018 (PDF); U.S. Department of Health and Human Services. March 2021.
4
Health Alert: California Department of Public Health Updates Syphilis Screening Recommendations, October 2024.
5
Dear Colleague Letter: Opt-Out Emergency Department HIV, HCV, and Syphilis Screening (PDF); California Department of Public Health. March 2022.
6
Summary of Laws and Regulations Related to Sexually Transmitted Disease Prevention and Control in California (PDF)ā; California Department of Public Health. May 2018.
7
Prenatal Syphilis Tesāting: Senate Bill 306 Fact Sheet (PDF); California Department of Public Health.
8 Stanford KA, Hazra A, Schneider J. Routine Opt-out Syphilis Screening in the Emergency Department: A Public Health Imperative. Academic Emergency Medicine. 2020;27(5):437-438. doi:10.1111/acem.13897
9 Chechi T, Sage AC, Tran N, Waldman S, May LS. 433. Implementation of an Emergency Department Syphilis Screening Program. Open Forum Infect Dis. 2019;6(Supplement_2):S216-S216. doi:10.1093/ofid/ofz360.506
10 Stanford K, Ridgway J, Schneider J. P740 Improving syphilis diagnosis and treatment in an urban population through routine emergency department screening. Sex Transm Infect. 2019;95(Suppl 1):A319-A320. doi:10.1136/sextrans-2019-sti.800
11 Stanford KA, Hazra A, Friedman E, Devlin S, Winkler N, Ridgway JP, Schneider J. Opt-out, routine emergency department syphilis screening as a novel intervention in at-risk populations. Sex Transm Dis. 2020 Oct 1. doi: 10.1097/OLQ.0000000000001311. Epub ahead of print. PMID: 33009277.
12 Larios Venegas A, Melbourne HM, Castillo IA, et al. Enhancing the Routine Screening Infrastructure to Address a Syphilis Epidemic in Miami-Dade County. Sexually Transmitted Diseases. 2020;47(5S):S61. doi:10.1097/OLQ.0000000000001133ā
āāāāāāāāāāāāāāāāāāāāāāāā